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The frequency of homozygous KLRC2 deletion was 13.7 % in 
Gambians and 4.7 % in Tanzanians. A significantly higher fre-
quency of the deletion allele was found in West-Africans from 
the Gambia and Guinea-Bissau (36.2 % p = 2.105 × 10−8, 
26.8 % p = 0.050; respectively) in comparison to East-African 
Tanzanians where the frequency of the deletion is comparable 
to other human populations (20.9 %). We found no evidence for 
an association between the numbers of KLRC2 gene copies and 
the clinical manifestations of trachoma (follicular trachoma or 
conjunctival scarring). A new method for imputation of KLRC2 
genotypes from single nucleotide polymorphism (SNP) data 
in 2621 individuals from the Gambia further confirmed these 
results. Our data suggest that NKG2C does not play a major 
role in trachomatous disease. We found that the deletion allele 
is present at different frequencies in different populations but the 
reason behind these differences is currently not understood. The 
new method offers the potential to use SNP arrays from genome 
wide association studies to study the frequency of KLRC2 dele-
tion in other populations and its association with other diseases.
Abbreviations
NK  Natural killer
KLRC2  Killer cell lectin-like receptor C2
TS  Trachomatous scarring
TF  Trachomatous inflammation-follicular
Introduction
Natural killer (NK) cells play a crucial role in innate and 
adaptive immune responses against virally infected and 
Abstract NKG2C is an activating receptor that is preferen-
tially expressed on natural killer (NK) cells. The gene encod-
ing NKG2C (killer cell lectin-like receptor C2, KLRC2) is 
present at different copy numbers in the genomes of different 
individuals. Deletion at the NKG2C locus was investigated in 
a case–control study of 1522 individuals indigenous to East- 
and West-Africa and the association with the ocular Chla-
mydia trachomatis infection and its sequelae was explored. 
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tumorigenic cells as well as in reproduction in placental 
mammals (Cerwenka and Lanier 2001; Moffett and Loke 
2006). NK cell functions range from cytotoxic activity to 
the production of cytokines such as TNF-α and IFN-γ. This 
variety of functions is controlled by the integrated action 
of activating and inhibitory receptors at the cell surface 
(Lanier 2005; Long et al. 2013). NK cell receptors include 
the killer-cell immunoglobulin-like receptors (KIRs) and 
the C-type lectin-like family of receptors. A high propor-
tion of the NK cell repertoire expresses inhibitory recep-
tors such as the C-type lectin-like NKG2A/CD94 dimers 
and inhibitory KIRs that bind to HLA-E and HLA class I 
ligands, respectively (Braud et al. 1998; Parham 2005). The 
recognition of HLA ligands by inhibitory receptors on NK 
cells restricts NK cell activation and targeted cytotoxicity. 
In the context of viral infection or malignant cell trans-
formation, the balance between inhibitory and activating 
signals is shifted and cells with down-regulated levels of 
HLA class I and HLA-E alleles become targets of activated 
NK cell subtypes (Lodoen and Lanier 2005; Wieten et al. 
2014).
NKG2C, the activating counterpart of NKG2A, is 
expressed by a different subtype of peripheral blood NK 
cells that also recognise non-classical HLA-E. Contrary to 
NKG2A that delivers inhibitory signals through its cyto-
plasmic ITIM motif; NKG2C/CD94 heterodimers associ-
ate with the ITAM motif of the adaptor protein DAP12 
to activate NK cells (Borrego et al. 1998; Braud et al. 
1998; Lee et al. 1998). A unique population of mature 
CD57+NKG2A−NKG2C+ NK cells undergoes selective 
expansion in response to infection with human cytomegalo-
virus (HCMV) (Della Chiesa et al. 2012; Foley et al. 2012a, 
b; Guma et al. 2004, 2006; Lopez-Verges et al. 2011) and 
other viral infections (Hantavirus, Chikungunya, HIV and 
Hepatitis B) (Beziat et al. 2012; Bjorkstrom et al. 2011; 
Brunetta et al. 2010; Petitdemange et al. 2011). Expan-
sion of NKG2C positive cells was also reported for non-
communicable diseases, including Stevens–Johnson syn-
drome and psoriasis (Batista et al. 2013; Morel et al. 2010). 
Importantly, the expansion of NKG2C positive NK cells in 
response to HIV and hepatitis B infections was restricted to 
HCMV seropositive patients (Beziat et al. 2012; Brunetta 
et al. 2010).
The NKG2C receptor is encoded by the KLRC2 gene, 
which is located in the NK complex (NKC) on chromo-
some 12p13. Heterozygous and homozygous KLRC2 gene 
deletion is present in different populations in a significant 
proportion of individuals (Hikami et al. 2003; Li et al. 
2015; Miyashita et al. 2004; Moraru et al. 2012b; Rangel-
Ramirez et al. 2014; Thomas et al. 2012). Deletion at the 
NKG2C locus has been shown to lead to an increased risk 
of HIV infection and faster disease progression (Thomas 
et al. 2012). An association between KLRC2 deletion and 
psoriasis has also been reported (Zeng et al. 2013). No 
apparent association has been found with other viral infec-
tions (Moraru et al. 2012b; Rangel-Ramirez et al. 2014) or 
with other diseases such as rheumatoid arthritis, systemic 
lupus erythematosus and nasopharyngeal carcinoma (Li 
et al. 2015; Miyashita et al. 2004). Recently, KLRC2 dele-
tion was shown to be associated with a reduction in the pro-
portion of mature NK cells expressing CD94 and CD57. 
Furthermore, children (but not adults) bearing the KLRC2 
deletion had significantly higher levels of anti-HCMV IgG 
antibodies, suggesting that NKG2C plays a role in the con-
trol of HCMV infection early in childhood (Goodier et al. 
2014). Interestingly, the association between KLRC2/
NKG2C deletion and intracellular bacterial infections has 
not been described so far.
Several pieces of evidence suggest that NK cells play 
a role in the resolution of infection with Chlamydia tra-
chomatis (Ct), a gram-negative obligate intracellular bac-
terium. Repeated ocular infection with Chlamydia tra-
chomatis serovars A, B and C causes trachoma, a blinding 
disease characterised by chronic conjunctival inflammation 
in childhood that develops into conjunctival scarring and 
blindness later in life (Hu et al. 2010). The mechanistic 
relationship between chronic inflammation and conjuncti-
val scarring is not completely understood. It has been sug-
gested that the scarring complications of trachoma occur 
as a result of the burden of infection and the host immune 
response itself (Derrick et al. 2015). The resolution of 
Ct infection requires an IFN-γ dependent Th1 mediated 
immune response (Derrick et al. 2015; Holland et al. 1996). 
Ct infection was shown to activate IFN-γ production by 
human NK cells along with activation of IFN-γ inducing 
cytokines (IL-18, IL-12) by epithelial and dendritic cells 
(Hook et al. 2004, 2005). NK cell-mediated cytotoxic-
ity of epithelial cells has also been described (Hook et al. 
2004). In vivo studies in mice have further demonstrated 
that NK cells are the source of early IFN-γ production in 
response to genital chlamydial infection (Tseng and Rank 
1998). NK cells were also shown to modulate Th1/Th17 
responses induced by lung dendritic cells upon Chlamydia 
muridarum infection (Shekhar et al. 2015). In humans 
living in trachoma endemic regions, NK cells have fur-
ther been identified as the primary source of early IFN-γ 
production, a response that increases with age (Gall et al. 
2011). Conjunctival gene expression studies have identi-
fied NK cell activation and cytotoxicity pathways associ-
ated with active disease (Natividad et al. 2010). Of par-
ticular note is the up-regulation of genes required for NK 
cell responses such as different NK cell receptors (KIRs 
and NCR3), perforin (PRF1) and granzyme B (GZMB). 
A recent study demonstrated that the odds of develop-
ing scarring trachoma increase with increasing number 
of genome copies of HLA-C2, which is further amplified 
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by heterozygosity at KIR2DL2/KIR2DL3 (Roberts et al. 
2014). Interestingly, in NKG2C positive NK cells there is 
a predominance of inhibitory KIRs that recognise HLA-C 
ligands (Beziat et al. 2012, 2013; Djaoud et al. 2013; Foley 
et al. 2012b; Horowitz et al. 2013). More recently, Hu et al. 
have shown evidence for NK cell infiltration in the conjunc-
tiva of patients with scarring trachoma (Hu et al. 2016). In 
line with the available evidence, we hypothesised that NK 
cells and signalling through NK cell receptors such as KIRs 
and NKG2C could be important risk factors for trachoma.
The frequency of the KLRC2 deletion has been investi-
gated in Mexican mestizos, Dutch, German, Spanish, Jap-
anese and Chinese populations (Li et al. 2015; Miyashita 
et al. 2004; Moraru et al. 2012b; Rangel-Ramirez et al. 
2014; Thomas et al. 2012). With the exception of the Mexi-
can mestizo population for which the KLRC2 deletion 
allele was found at a frequency of approximately 10.3 %, 
the frequency of the deletion haplotype seems to be compa-
rable among the other populations studied (17.5–21.9 %). 
We have previously reported that in a limited number of 
Gambians from a single district, the frequency of NKG2C 
deletion was 29.3 % (Goodier et al. 2014). The reason 
behind the maintenance of NKG2C deletion in different 
populations is currently not understood and studies looking 
at the frequency of NKG2C deletion in different African 
populations are lacking.
In this study, we compare and quantify the frequency 
of KLRC2/NKG2C deletion in different African popula-
tions (East- and West-Africa) where trachoma is or has 
been endemic at the time of sample collection. We are the 
first to investigate the association between NKG2C/KLRC2 
deletion and the different stages of trachomatous disease; 
trachomatous inflammation-follicular (TF) a reversible 
clinical sign of active disease in children and trachomatous 
scarring (TS), believed to be irreversible, that develops over 
time. We also describe a new method for KLRC2/NKG2C 
genotype imputation from single nucleotide polymorphism 
(SNP) genotyping data.
Methodology
Ethics statement
The study was conducted in accordance with the Decla-
ration of Helsinki. Samples included in the study were 
obtained from anonymous archived genomic DNA stocks. 
Permission for collection of samples/specimens and geno-
typing was granted by the relevant local and national ethics 
committees of the London School of Hygiene and Tropi-
cal Medicine, The Gambian Government/Medical Research 
Council Unit, the Comité Nacional de Ética em Saúde of 
Guinea Bissau, Kilimanjaro Christian Medical College 
Ethics Committee and the National Institute for Medical 
Research Ethics Committee in Tanzania. Written informed 
consent prior to a participant’s enrolment was obtained 
from all adult participants and from a parent or a guardian 
for participants aged under 18 years.
Study populations
Participants were recruited from multiple rural regions 
in the Gambia, from Maasai communities in Kiliman-
jaro Region, Tanzania and from seven islands of the Bija-
gos Archipelago in Guinea-Bissau (Derrick et al. 2016a, 
b; Roberts et al. 2015). Genotyping was performed using 
buccal swab isolated genomic DNA from a subset of par-
ticipants from these studies selected at random: a total of 
226 children (1–13 years old) with or without trachoma-
tous inflammation-follicular (TF) and 1296 individuals 
(0–103 years old) with or without trachomatous scarring 
(TS). In detail, a total of 62 children from the Gambia, 
164 children from Guinea-Bissau, 509 Tanzanian Maasai 
adults and 787 Gambians (out of which 174 were chil-
dren ≤13 years old) were genotyped by sequence-specific 
primer-PCR (SSP-PCR). Blood was further collected from 
a sample of 76 Gambian adults and peripheral blood mono-
nuclear cells (PBMCs) were isolated by density gradient 
centrifugation for flow cytometric analysis. Clinical grades 
of trachoma were obtained using the WHO simplified tra-
choma grading system (WHO simplified trachoma grading 
system 2004) and the WHO 1981 FPC trachoma grading 
system (Dawson 1981). TF cases were identified as indi-
viduals presenting with follicular scores of “F2” or “F3” 
using the FPC system; whereas individuals with no clinical 
signs of follicles (F0), papillary hypertrophy (P0) or con-
junctival scarring (C0) were identified as controls. TS cases 
were identified as individuals presenting conjunctival scar-
ring in either eye according to the WHO simplified system.
KLRC2/NKG2C genotyping
KLRC2 genotypes were determined by touchdown PCR 
using the Phusion High Fidelity PCR kit (New England 
Biolabs) according to previously described methods (Good-
ier et al. 2014). Primer sequences were derived from the lit-
erature (Miyashita et al. 2004; Moraru et al. 2012a) with 
minor modifications. The primers for detection of the wild-
type allele generate a 200-bp product (Forward primer: 
5′-AGTGTGGATCTTCAATGATA-3′; Reverse primer: 
5′-TTTAGTAATTGTGTGCATCCT-3′). The second primer 
pair detects the deletion allele yielding a 411-bp product 
(Forward primer: 5′ACTCGGATTTCTATTTGATGC3′; 
Reverse primer: 5′ACAAGTGATGTATAAGAAAAAG3′. 
When the KLRC2 gene is present, the deletion primer pair 
(411 bp) fails to generate a product and only the 211-bp 
942 Hum Genet (2016) 135:939–951
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product within the KLRC2 gene is detected. In the absence 
of the KLRC2 gene, the distance between the deletion prim-
ers is decreased and a 411-bp product can then effectively 
be detected as a result of the deletion. Using this method, 
individuals expressing two copies of KLRC2 (wt/wt), one 
copy of KLRC2 (wt/del) or homozygous for the 16-Kb 
deletion (del/del) were identified. Touchdown PCR was 
carried out as previously described (Goodier et al. 2014). 
Specifically, initial denaturation was performed at 95 °C for 
3 min, followed by 10 cycles of denaturation at 94 °C for 
30 s, annealing for 30 s from 65 to 55 °C (65 °C on the 
first cycle and minus one degree per cycle) and extension 
at 72 °C for 30 s, followed by 26 cycles of denaturation at 
94 °C for 30 s, annealing at 55 °C for 30 s and extension 
at 72 °C for 30 s. PCR products were separated and iden-
tified using agarose gel electrophoresis. The primers and 
genotyping method were optimised and validated against a 
panel of reference cells lines (Moraru et al. 2012a). Geno-
types were assigned by blinded visual inspection of the gels 
in batches of up to 95 samples per assay. Unsuccessful gen-
otyping results were not included in the analysis.
Flow cytometry
Genotyping results were further confirmed by flow cytom-
etry analysis of NKG2C protein expression at the surface 
of peripheral blood CD3 negative and CD56 positive NK 
cells in a subgroup of individuals from the study (N = 76). 
PBMCs were incubated with the following monoclonal 
antibodies: CD56 PE Cy7; CD3 V500 (BD Biosciences, 
Oxford, UK) and NKG2C PE (R&D Systems, Abingdon, 
UK) as previously described (Goodier et al. 2014). Cells 
were acquired on an LSRII flow cytometer using FacsDiva 
software (BD biosciences) and data were analysed using 
FlowJo (Treestar Inc., Ashland, OR, USA).
Statistical analysis
Genetic associations were investigated, analysed and 
reported according to the Strengthening the Reporting of 
Genetic Association studies (STREGA) recommendations 
(Little et al. 2009). The genotyping data were analysed 
using R (https://www.r-project.org/) and STATA version 
14.1 (StataCorp LP, College Station, TX, USA). Geno-
type frequencies were tested for deviation from Hardy–
Weinberg equilibrium prior to the association analysis. A 
multivariable logistic regression was performed to inves-
tigate the association between KLRC2/NKG2C genotype 
and trachomatous disease (either TF for active disease 
in childhood or TS for conjunctival scarring). The asso-
ciation between genotype and TF was measured in West-
African children from the Gambia and Guinea-Bissau. 
The association between genotype and TS was measured 
in West-African Gambians (multiple ethnicities) and East-
African Tanzanian Maasai. Genotype was used as the 
explanatory variable and is divided in three levels (wt/wt, 
wt/del, del/del). Age and gender were included a priori in 
the model as potential confounders. Confounding by ethnic 
origin was controlled for in the Gambian population. Tabu-
lation of the different variables and cross-tabulation with 
the outcome was used to access the distribution of the study 
sample and identify missing data. Missing data (≥5 %) was 
accounted for during the statistical analysis.
Genotype data from this study and previous published 
research (Li et al. 2015; Miyashita et al. 2004; Moraru 
et al. 2012b; Rangel-Ramirez et al. 2014; Thomas et al. 
2012) were used to determine the association between 
origin of study population and the frequency of the dele-
tion allele in healthy controls. Origin of population was 
grouped in accordance to the 1000 genomes project (http://
www.1000genomes.org) into: Tanzanians (Maasai), West-
Africans (Gambians and Bissau-Guineans), Europeans 
(Germans, Dutch and Spanish), East-Asians (Chinese and 
Japanese) and Mexican Mestizos. The association was 
determined using a logistic regression model in which the 
outcome was each individual allele (0/1 for wild-type and 
deletion alleles, respectively) and the explanatory variable 
was the origin of the population. Statistical hypotheses 
were evaluated using the Wald-test and the likelihood ratio 
test (LRT).
Imputation of KLRC2/NKG2C genotypes from SNP 
genotyping data
KLRC2 deletion variant genotypes were imputed from com-
mercial single nucleotide polymorphism (SNP) genotyping 
arrays in 1090 TS cases and 1531 controls from the Gam-
bia. All specimens had previously been directly genotyped 
at 1,467,876 SNPs using HumanOmni2.5-8v1_A arrays 
(Illumina Inc, San Diego, CA. USA) (Roberts et al. 2015). 
Imputation was used to increase the number of directly or 
indirectly genotyped SNPs to 11,851,747 SNPs, including 
2,960,018 on chromosome 12. Genotyping, imputation and 
quality control of this data are described in a previous publi-
cation (Roberts et al. 2015). Of the 2621 specimens included 
in this analysis, 145 cases and 164 controls (n = 309) were 
also genotyped for the KLRC2 deletion variant by SSP-
PCR. For the 309 specimens that were included in both 
studies, we merged the KLRC2 genotyping data with chro-
mosome 12 SNP data using R and PLINK. Pairwise Link-
age Disequilibrium (LD) was estimated between the KLRC2 
deletion polymorphism and each SNP in chromosome 12. 
All SNPs in LD with the deletion variant with LD R2 >0.2 
were initially selected as candidate markers for use in a clas-
sification model. Random Forest, implemented through the 
Ranger package for R (Wright and Ziegler 2015), was used 
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to estimate the relative importance of SNPs in determining 
the KLRC2 genotype. The predictions of the machine-learn-
ing model (using all SNPs with R2 >0.2) were compared to 
the true genotypes and Cohen’s Kappa was used to deter-
mine the extent of agreement between the predicted and 
genotyped data. We aimed to minimise the number of SNPs 
required for accurate classification whilst not impacting 
significantly on classification accuracy. The classification 
model was run again using only the top 1, 2, 3 or 4 SNPs 
according to the estimates of variable importance. Cohen’s 
kappa was used, along with the number of misclassifications 
observed in cross-tabulation, to identify the best 1–4 SNP 
model that could be used to impute the KLRC2 genotype. 
The model with the fewest misclassifications and highest 
unbiased Kappa estimate was selected as the final classifier.
Finally, we selected all specimens from the Gam-
bian case control sample in which there were no missing 
data for the SNPs selected as the components of the best 
Random Forest model. We then applied the model to the 
imputation of the NKG2C genotype in 1010 cases of TS 
and 1419 controls. The imputed genotypes were tested for 
Hardy–Weinberg equilibrium using a likelihood-ratio test. 
Test of association between imputed KLRC2 genotype and 
TS phenotype was performed using logistic regression, 
including gender and age as covariates.
Results
Validation of the NKG2C/KLRC2 genotyping method
NKG2C/KLRC2 genotyping methods initially developed 
by Myashita et al. (2004) were further optimised to specifi-
cally recognise the KLRC2 gene and used to characterise 
a panel of reference cell lines (Moraru et al. 2012a). The 
primers and genotyping method used in this study were 
modified from those published by Moraru et al. and have 
been published elsewhere (Goodier et al. 2014). In order to 
validate our approach and rule out the possibility of cross-
amplification of highly homologous genes (e.g. the gene 
encoding the NKG2A receptor), we tested our primers on 
a set of previously published reference cell lines (Moraru 
et al. 2012a). Our method accurately determined the geno-
types of all 14 cell lines tested (Supplementary Figure 1A). 
Furthermore, flow cytometry analysis in a sample of 76 
individuals confirmed that absence of the KLRC2 gene 
translates into lack of NKG2C expression on the surface of 
NK cells in all 13 individuals homozygous for the KLRC2 
deletion. In line with previously published observations 
(Muntasell et al. 2013; Noyola et al. 2012; Thomas et al. 
2012), we found a significant correlation between the mean 
fluorescence intensity (MFI) of the NKG2C staining and 
increasing number of KLRC2 gene copies (Supplementary 
Figure 1B, C). Genotyping was successful in 1522/1561 
(97.5 %). Genotyping failure occurred in 15 Gambian 
and 24 Tanzanian specimens. The number of failures was 
comparable between cases and controls (not shown). All 
39 individuals with unsuccessful genotyping results were 
excluded from the study.
Association between KLRC2 genotype 
and Trachomatous disease
A total of 1522 individuals were genotyped: 1013 from 
West-Africa (Gambia and Guinea-Bissau) and 509 from the 
Maasai community in Tanzania. The association between 
KLRC2/NKG2C deletion and TS was investigated in 787 
Gambians [314 Mandinka (39.9 %); 236 Jola (30.0 %) and 
237 (30.1 %) from other ethnicities] and 509 Maasai Tan-
zanians (Table 1). Sample size was estimated to achieve 
80 % power to detect a 1.5 effect size at the 0.05 signifi-
cance level in an additive genetic model. Furthermore, a 
total of 226 children (62 Gambians and 164 Bijagos-island-
ers) with and without TF were genotyped to determine the 
association between KLRC2 deletion and active disease. 
The distribution of KLRC2 genotypes in all three popu-
lations (Table 1) was compatible with Hardy–Weinberg 
equilibrium (p > 0.05). The association between KLRC2 
genotypes and clinical signs of trachoma was investigated 
by multivariate logistic regression including age and gen-
der in the model. As expected, there was strong evidence 
(p < 0.001) that the odds of TS increase with increasing 
age in both populations studied (Table 2). After adjusting 
for age and genotype, we found evidence (p = 0.02) that 
Tanzanian females have higher relative odds of TS as com-
pared to males (OR 1.68 95 % CI: 1.08–2.62). There was 
no apparent association between KLRC2 genotype and 
TS in either West-African Gambians (p = 0.909) or East-
African Tanzanian Maasai (p = 0.417) (Table 2). There 
was also no evidence of an association (p = 0.852) between 
KLRC2 genotype and TS in West-African Gambians after 
adjusting for ethnic origin (Supplementary Table 1). Evi-
dence for an association between KLRC genotype and 
active disease (TF) was also not found in West-African 
children (p = 0.617) (Supplementary Table 2). Overall, the 
data suggest that there is no association between the num-
ber of NKG2C/KLRC2 copies and the clinical manifesta-
tions of ocular C. trachomatis infection in different human 
populations with endemic trachoma. 
Lack of association with scarring trachoma in Gambian 
adults confirmed by imputed KLRC2 genotypes 
from SNP genotyping data
A new method for imputation of NKG2C/KLRC2 geno-
types from SNP genotyping data was developed. KLRC2 
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deletion variant genotypes were imputed from commercial 
SNP genotyping array results in 1090 TS cases and 1531 
controls from the Gambia. One hundred and eleven SNPs 
were found to be in linkage disequilibrium (LD) with the 
KLRC2 deletion variant (R2 > 0.2). The SNP in strong-
est LD with the variant was rs12318583 (R2 = 0.937), 
followed by rs2246809 (R2 = 0.889) and rs2734561 
(R2 = 0.888). Figure 1 shows the genomic region of the 
KLRC2 deletion variant and highlights SNPs in the region 
that are in LD with this variant. Figure 2 shows the relative 
variable importance of each of 111 SNPs in Random Forest 
classification. The 111 SNP Random Forest was applied to 
the 309 specimens of the training set and imputation was 
found to be accurate in 291/309 (94.17 %) of specimens. 
Table 3 shows concordant and discrepant calls between the 
genotyped and imputed data. The three SNPs in highest LD 
with the KLRC2 deletion were found to be the components 
of the best classifier model, which correctly imputed the 
genotype in 292/309 (94.5 %) specimens (Table 4).   
The three SNP Random Forest was applied to 1010 
Gambian cases of TS and 1419 controls from the same pop-
ulation. The imputed genotype counts were 932 (wt/wt), 
1138 (wt/del) and 359 (del/del). The imputed KLRC2 geno-
types were in Hardy–Weinberg equilibrium (p = 0.74). 
There was no statistically significant association between 
the KLRC2 genotype and TS in this population (Table 5). 
These results are consistent with our results in Gambians 
Table 2  Adjusted odds ratios 
(age and gender) for the 
association between KLRC2 
genotypes and trachomatous 
scarring (TS); estimated by 
logistic regression
West-Africans (Gambians); East-Africans (Tanzanians Maasai)
OR odds ratio (adjusted for all other variables in the table), CI confidence interval
* Wald test (left), Likelihood Ratio Test (right)
West-Africans (N = 787) East-Africans (N = 509)
OR 95 % CI p value* OR 95 % CI p value*
Genotype
 wt/wt 1 – – 0.908 1 – – 0.417
 wt/del 1.03 0.75–1.41 0.843 0.81 0.53–1.24 0.329
 del/del 1.11 0.70–1.75 0.663 0.62 0.25–1.55 0.307
Age 1.02 1.01–1.02 8.325 × 10−7 1.07 1.05–1.08 4.466 × 10−18
Gender 0.80 0.58–1.10 0.164 1.68 1.08–2.62 0.021
Fig. 1  Imputation of KLRC2 genotypes from SNPs. Patterns of LD 
with the deletion variant in the training set. Dashed line shows the 
limits of the deletion. Closed lines show the location of the NKG2C 
gene in wild-type chromosomes. 111 SNPs were in LD with the dele-
tion with R2 >0.2: 0.2–0.4 (blue), 0.4–0.6 (green), 0.6–0.8 (amber), 
>0.8 (pink). Nucleotide position based on URCh37.p13 Annotation 
release 105 (colour figure online)
Fig. 2  Imputation of KLRC2 from SNPs. Variable importance in 
random forest classification. A small number of SNPs had impor-
tance for a predictive model. The model was dominated by the effects 
of three SNPs of large importance to the decision forest. The three 
most important SNPs were rs12318583 (y = 17.0352561), rs2734561 
(y = 16.1572070) and rs2246809 (y = 12.9735736)
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obtained by direct SSP-PCR genotyping (Table 2). The 
greater sample size (N = 2621) provided increased power 
(85 %) to detect smaller effect sizes (1.2) at the 0.05 sig-
nificance level. Altogether, the results suggest that there is 
no association between KLRC2 genotype and trachomatous 
disease, which imparts an increase in relative risk of dis-
ease that is greater than 1.2.
KLRC2 deletion is present at higher frequencies 
in West‑African populations
The frequency of KLRC2 deletion allele was compared 
among different populations (Table 6). Previous studies 
examining the frequency of KLRC2 deletion have reported 
frequencies ranging within 17–23 % in different Euro-
pean and East-Asian populations (Miyashita et al. 2004; 
Moraru et al. 2012b; Rangel-Ramirez et al. 2014; Thomas 
et al. 2012). Li et al. have compiled this information and 
demonstrated that, with the exception of the Mexican mes-
tizo population where the frequency is lower (10.3 %), the 
frequency of KLRC2 deletion among different European 
and East-Asian populations is in general comparable (Li 
et al. 2015; Rangel-Ramirez et al. 2014). We investigated 
the frequency of KLRC2 deletion among different African 
populations. In East-African Maasai Tanzanians, the fre-
quency of KLRC2 deletion (20.9 %) was comparable to 
the frequencies observed in Europeans (p = 0.398) and 
East-Asians (p = 0.773). In contrast, we found strong evi-
dence (p = 1.110 × 10−6) that the KLRC2 deletion allele 
is present at higher frequency in West-African populations 
(33.2 %) (Table 6). The frequency of the KLRC2 deletion 
allele was the highest among Gambians (36.2 %; p = 2.105 
× 10−8) followed by Bissau-Guineans (26.8 %; p = 0.050). 
West-African populations have approximately two times 
the odds of having the KLRC2 deletion allele when com-
pared to East-African Maasai Tanzanians (OR = 1.88; 
95 % CI 1.46–2.43). Conversely, the odds of having the 
KLRC2 deletion are about two times lower (OR = 0.44; 
95 % CI 0.31–0.61) among Mexican mestizos (10.3 %) 
compared to Maasai Tanzanians. Collectively, the results 
suggest that KLRC2 deletion is found at different levels 
within distinct human populations.
Discussion
Deletion of KLRC2 gene was first reported in 2003 in a 
Japanese population (Hikami et al. 2003) and subsequently 
in other contemporary human populations (Li et al. 2015; 
Miyashita et al. 2004; Moraru et al. 2012b; Rangel-Ram-
irez et al. 2014; Thomas et al. 2012). Goodier et al. meas-
ured the frequency of the deletion haplotype in a small 
cohort of Gambians. Consistent with our results, the fre-
quency of the deletion haplotype in this cohort was higher 
than documented elsewhere (Goodier et al. 2014). Our 
study is the first to report the frequency of KLRC2 deletion 
in different African populations. The deletion haplotype 
is present at relatively high frequencies in distinct human 
populations ranging from approximately 10 % in Mexican 
Table 3  Random forest agreement with experimental data in training 
set, 111 SNP model
Cohen’s Kappa = 0.91 unweighted (CI 0.86–0.95), weighted 0.94 (CI 
0.91–0.97)
Imputed genotype Experimental genotype
wt/wt wt/del del/del
wt/wt 119 2 0
wt/del 10 127 3
del/del 0 3 45
Table 4  Selection of best classifier model (SNPs 1-5)
Model Accuracy n/309 (%) Cohen’s Kappa, unweighted Cohen’s Kappa, weighted
rs2246809 289 (93.5) 0.90 (0.85–0.94) 0.94 (0.91–0.96)
rs2246809 + rs2734561 289 (93.5) 0.90 (0.85–0.94) 0.94 (0.91–0.96)
rs2246809 + rs2734561 + rs12318583 292 (94.5) 0.91 (0.87–0.95) 0.95 (0.92–0.97)
rs2246809 + rs2734561 + rs12318583 + rs1382264 291 (94.1) 0.91 (0.86–0.95) 0.94 (0.91–0.97)
rs2246809 + rs2734561 + rs12318583 + rs1382264  
+ rs1382264
292 (94.5) 0.91 (0.87–0.95) 0.95 (0.92–0.97)
Table 5  Association between TS and KLRC2 genotype in 2429 
Gambian specimens
West-Africans (N = 2429)
OR (95 % CI) Z p value
Genotype
 wt/wt 1 – –
 wt/del 1.093 (0.998–1.196) 0.980 0.327
 del/del 1.138 (1.002–1.291) 1.018 0.309
Gender 1.389 (1.272–1.517) 3.732 0.0002
Age 1.007 (1.004–1.008) 3.420 0.0006
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mestizos (Rangel-Ramirez et al. 2014) to 36 % in West-
African Gambians.
We have confirmed that copy number variation at the 
KLRC2 locus correlates with the expression levels of func-
tional NKG2C receptor on NK cells as previously reported 
(Muntasell et al. 2013; Noyola et al. 2012; Thomas et al. 
2012). The high population frequency of KLRC2 deletion 
that disrupts the expression of the receptor suggests that 
NKG2C is not essential for survival and other receptors 
might compensate for the lack of NKG2C on immune cells. 
CMV expanded NKG2C positive cells also express inhibi-
tory KIR receptors specific for self–HLA-C (Beziat et al. 
2012, 2013; Djaoud et al. 2013; Foley et al. 2012b; Horow-
itz et al. 2013). It is conceivable to hypothesise that KIR or 
other receptors can compensate for the lack of NKG2C in 
KLRC2 negative individuals so that NKG2C deletion can be 
maintained without higher costs in populations. Future stud-
ies looking at the function and receptor diversity of CMV 
expanded NK cells in NKG2C positive and NKG2C negative 
individuals are likely to address some of these questions.
Myashita et al. hypothesised that the KLRC2 deletion 
has emerged as a result of an unequal ancient crossover 
event. Shared nucleotides exclusive to the deletion haplo-
type in individuals from distinct populations (Miyashita 
et al. 2004) along with the global distribution of the dele-
tion haplotype suggest that the deletion originated from a 
common ancestral event. The exact origin of the deletion 
event and what form of selection (for instance balancing or 
frequency dependent selection) drove the maintenance of 
the deletion haplotype at different frequencies in the differ-
ent populations are currently not understood.
Of particular notice is the lower frequency of the 
KLRC2 deletion in Mexican mestizos (10.3 %; p = 1.927 
× 10−6) and the higher frequency of the KLRC2 deletion 
in West-African populations from The Gambia and Guinea-
Bissau (33.2 %, p = 1.110 × 10−6). Interestingly, HLA-C2 
epitopes as well as centromeric KIR B haplotypes have also 
been found at higher frequencies in West Africans (Hollen-
bach et al. 2012; Roberts et al. 2014). Differential selective 
pressures, patterns of modern human migrations, admix-
ture, bottlenecks and gene flow may all account for these 
observations. The results are consistent with evidence that 
supports an African origin of anatomically modern humans 
who have consequently migrated into Eurasia and later 
spread into other parts of the globe including the Ameri-
cas (Campbell and Tishkoff 2008), where a high level of 
genetic drift is expected. Rangel-Ramirez et al. believe that 
the frequency of the KLRC2 deletion might be even lower 
in Native American populations as compared to the mixed 
Mexican mestizo population, which also has Caucasian 
origin (Rangel-Ramirez et al. 2014). Our data are further 
supported by research on African genetic structure where 
a differential gene clustering has been observed between 
East- and West-African populations (Tishkoff et al. 2009). 
Due to the variable degrees of population movements, 
expansions and admixture between Africans, different 
modern and ancient hunter-gatherer populations, West 
Eurasians and even archaic introgression (Gallego Llorente 
et al. 2015; Gurdasani et al. 2015; Racimo et al. 2015), one 
cannot exclude a more recent origin of the KLRC2 dele-
tion. Llorente et al. have recently shown that the Eurasian 
component in African populations is higher than previously 
Table 6  Odds ratios for the association between the frequency of the KLRC2 deletion allele and origin of the study population
Origin
Total number 
of alleles 
(2n)
Number (%) 
deletion allele OR (95 % CI) p value∞
East-Africans 488 102 (20.9 %) 1 –
West-Africans 1018 338 (33.2 %) 1.88 (1.46–2.43) 1.110 × 10-6
Gambians 690 250 (36.2 %) 2.15 (1.65–2.81) 2.105 × 10-8
Bissau-Guineans 328 88 (26.8 %) 1.39 (1.00–1.93) 0.050
Europeans
*
1044 199 (19.1 %) 0.89 (0.68–1.16) 0.398
East-Asians 1128 243 (21.5 %) 1.04 (0.80–1.35) 0.773
Mexicans (Rangel-Ramirez et 
al. 2014)
600 62 (10.3 %) 0.44 (0.31–0.61) 1.927 × 10-6
* East-Africans (Tanzanians Maasai); West-Africans (Gambians, Bissau-Guineans); Europeans [Germans (Thomas et al. 2012), Dutch 
(Miyashita et al. 2004) and Spanish (Moraru et al. 2012b)]; East-Asians [Chinese (Li et al. 2015) and Japanese (Miyashita et al. 2004)]; grey 
shade = this study (all individuals without TS included); genotypes in Hardy–Weinberg equilibrium
OR odds ratio, CI confidence interval
∞ Wald-test
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expected with the highest levels of admixture found in 
East Africa but extending all the way to West and Southern 
Africa, with some African populations showing up to 7 % 
of their genomes to be of Eurasian origin (Gallego Llorente 
et al. 2015).
As humans migrated and settled into different environ-
ments, they were exposed to a variety of pathogens and 
other environmental pressures. Natural selection of alleles 
that confer advantage to new ecosystems occurs for both 
humans and pathogens. Infectious diseases are among the 
most predominant selective pressures that act on humans 
throughout evolution (Fumagalli et al. 2011). Since the 
KLRC2 deletion is present in different populations, we 
hypothesise that it may provide selective advantage to a 
particular environment. Since both wild-type and dele-
tion alleles can be found at high frequencies in the popu-
lation, a balancing selection that favours diversity seems 
to be the most plausible model. In fact, a wide variety of 
immune response genes including the major histocompat-
ibility complex (MHC) and KIR haplotypes are thought to 
be maintained in human populations by balancing selec-
tion (Karlsson et al. 2014; Parham and Moffett 2013). This 
mechanism favours diversity, which is required to deal with 
the broad range of pathogens that affects humans. In the 
case of the KIR haplotypes it has been proposed that the 
balanced selection of KIR A and B haplotypes in all human 
populations is related to the distinct and complementary 
functions of NK cells in both immunity and reproduction 
(Parham and Moffett 2013). The role of KLRC2 deletion 
in reproduction has not been addressed so far and it would 
be interesting to study whether KLRC2 deletion has any 
impact in this context. In the context of infection, KLRC2 
deletion was shown to be associated with impaired out-
comes to CMV, HIV infection and psoriasis (Goodier et al. 
2014; Thomas et al. 2012; Zeng et al. 2013). In this study, 
we have found no evidence for an association between 
KLRC2 deletion and trachoma in different African popula-
tions where trachoma has historically been hyper-endemic. 
It is, therefore, unlikely that any of the diseases studied 
to date are responsible for the maintenance of the KLRC2 
deletion in human populations. Even though we were well-
powered (85 %) to detect small effect sizes (as low as 1.2) 
at the 0.05 significance level, we cannot rule out that com-
mon sources of bias (such as the non-differential number of 
samples excluded from the study due to genotyping failure 
or residual confounding) may have shifted the association 
towards the null. We have addressed potential sources of 
bias by validating and optimising our genotyping method 
against flow cytometry and a panel of reference cell lines 
and we have obtained a low genotype failure rate of 2.5 %. 
We have also confirmed that TS is associated with age and 
gender as previously described (Courtright and West 2004; 
Wolle et al. 2009). In these analyses, we did not make 
corrections for pairwise kinship between individuals. We 
have previously identified (Roberts et al. 2015) that cryptic 
kinship exists in the Gambian population in which we are 
working and this was demonstrated to cause genome-wide 
inflation of association test statistics in a genome-wide 
association scan. In order to control for cryptic kinship 
in these analyses, we would have needed access to high-
density SNP genotyping for all participants and in all three 
populations. Such data were not available and in the con-
text of a null result, we expect that inflation of the test sta-
tistic was not a problem that needed to be addressed here.
Contrary to KLRC2 deletion, HLA-C2 and 
KIR2DL2/2DL3 heterozygosity was shown to be associ-
ated with conjunctival scarring (Roberts et al. 2014) and a 
number of different KIR and HLA constellations have been 
shown to be associated with various infectious diseases, 
reproduction and survival. Altogether, these results suggest 
that NK cell receptors are predominant targets of selective 
pressures and that these pressures come from highly preva-
lent infectious diseases, highly selective prenatal and peri-
natal complications; as well as the double-edged threat of 
infection related infertility, for example due to genital C. 
trachomatis infection.
Further genetic association studies in additional human 
populations would be required to understand how and why 
the deletion has been maintained in humans. It would also 
be of interest to investigate why the deletion is present 
at such a high frequency in West Africa, and the role of 
NKG2C in pregnancy might warrant further research.
In order to investigate the impact of large genetic dele-
tions with a high degree of homology with other genes in 
the same genomic region (such as KLRC2 and other KLRC 
genes in the NKC region), a candidate gene approach is 
often more appropriate than genome wide association stud-
ies (GWAS). On the other hand, GWAS provide large and 
well-documented cohorts of patients that offer more power 
to detect disease associations and signatures of selection. 
GWAS can be further exploited for genetic analysis such 
as copy number variations (Hinds et al. 2006; McCarroll 
2008). We have shown that information contained in three 
SNPs is enough to predict KLRC2 genotypes with an accu-
racy of 94.5 %. Even though the results need to be vali-
dated in other populations, this method could in principle 
be used to impute KLRC2 genotype data from a variety 
of different populations for which SNP genotyping array 
data are available. Taken alone, the SNP rs2246809 is also 
highly accurate as a classifier tag-SNP, meaning that a sim-
ple SNP genotyping assay could replace the cumbersome 
agarose PCR approach and achieve more than 90 % accu-
racy in classification of samples which have not previously 
been genotyped by any method. This would provide an eas-
ier and faster alternative to advance our knowledge on the 
relevance of KLRC2 deletions in human populations. The 
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method described to identify SNPs in LD that can be used 
in genotype classification can be easily applied to other 
gene deletions or regions where GWAS data are available 
in large bio-bank collections. The three SNPs used in the 
model were all imputed SNPs, rather than having been 
directly genotyped in the GWAS panel. This means that 
there is no additional burden in using three as opposed to 
one SNP, whilst there is some marginal gain in using the 
full model.
Genotyping complex loci such as KLRC2, KIR and 
HLA is both methodologically challenging and expen-
sive. The development of simple and user friendly impu-
tation tools such as this Random Forest implementation 
for KLRC2 immunogenetic typing presents opportunities 
for many research groups, without resources to conduct 
GWAS, to access large publicly available data-sets. This is 
complementary to recent papers that have described tools 
for HLA (Zheng et al. 2014) and KIR (Vukcevic et al. 
2015) imputation, some of which (Levin et al. 2014) have 
been applied in specimens from people of African descent. 
As we perform more immuno-genotyping in cohorts that 
have also been tested using high-density SNP genotyping 
arrays, we approach a tipping point in immuno-genomics, 
where methodologically complex genotyping methods can 
begin to be replaced with statistical models of prediction 
that utilise more widely available SNP data.
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